This article is more than 5 years old. Information may no longer be current.
Aspiration system for stroke treatment receives FDA clearance
Click Here to Manage Email Alerts
Medtronic announced the FDA clearance of an aspiration system for use in the treatment of acute ischemic stroke.
According to a press release from the company, the aspiration system (Riptide) is designed to retrieve thrombus and restore blood flow in patients experiencing ischemic stroke as a secondary treatment to intracranial large vessel occlusive disease within 8 hours of symptom onset.
Candidates for treatment are those who are ineligible for IV tissue plasminogen activator or who fail IV tPA, according to the release.
“I utilize a direct aspiration approach as my first-line treatment strategy in select circumstances such as basilar thromboembolism and in select anterior circulation cases,” Daniel Sahlein, MD, interventional radiologist at Goodman Campbell Brain and Spine and assistant professor of clinical neurology in the department of neurological surgery at Indianapolis University-Purdue University Indianapolis,” said in the release. “The Riptide Aspiration System will provide me with another proven Medtronic product to utilize when treating stroke patients.”
Disclosure: Cardiology Today’s Intervention was unable to obtain relevant financial disclosures for Sahlein.